Iovance Biotherapeutics Inc at Jefferies Healthcare Conference Transcript
Thank you very much. Thank you for joining us on the afternoon session here. Really happy to have up here with me and the team from Iovance, specifically the interim CEO, Fred Vogt. Fred is going to make a couple of opening comments from the slides, and then we'll have a chance to do some questions and answers. And if you have a question, raise your hand. But I know I've got all the good questions. So I'll let you take the...
All right. Thanks, and thank you for the invitation. This is fantastic to get to see everybody in person. I'll be making some forward-looking statements today, so please take a look at the disclaimer.
I'll just give you a brief summary of Iovance really quickly, and then we'll go to the fireside chat. Here's Iovance by the numbers. We're the global leader in developing innovating TIL therapies, tumor-infiltrating lymphocyte therapies, which are
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
